Remnants of chylomicron and very low density lipoprotein impair endothelium-dependent vasorelaxation

Atherosclerosis

Volumn 137, Issue 2, 1998, Pages 341-349

  Doi, Hideki ^a   Kugiyama, Kiyotaka ^a   Ohgushi, Masamichi ^a   Sugiyama, Seigo ^a   Matsumura, Toshiyuki ^a   Ohta, Yasutaka ^a   Nakano, Takamitsu ^b   Nakajima, Katsuyuki ^b   Yasue, Hirofumi ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^b JAPAN IMMUNORESEARCH LABORATORIES   (Japan)

Author keywords

Endothelium; Endothelium derived relaxation factor; Hyperlipoproteinemia; Lipoproteins; Vasodilation

Indexed keywords

ACETYLCHOLINE; CALCIMYCIN; CHYLOMICRON; NITROPRUSSIDE SODIUM; SUBSTANCE P; TRIACYLGLYCEROL; VASODILATOR AGENT; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; HUMAN; HYPERLIPOPROTEINEMIA; NONHUMAN; PRIORITY JOURNAL; RABBIT; VASCULAR ENDOTHELIUM; VASODILATATION;

ACETYLCHOLINE; ANIMALS; AORTA; CALCIMYCIN; CELLS, CULTURED; CHYLOMICRONS; ELECTROPHORESIS, AGAR GEL; ENDOTHELIUM, VASCULAR; HUMANS; IONOPHORES; LIPOPROTEINS, VLDL; MALE; RABBITS; UMBILICAL VEINS; VASODILATION;

EID: 0032055382     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(97)00291-8     Document Type: Article

References (46)

1. Lipid Research Clinics Coronary Primary Prevention Trial Results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. J Am Med Assoc 1984;251:365.
2. Austin M.A. Plasma triglyceride and coronary heart disease. Arterioscler Thromb. 11:1991;2-14.
3. Zilversmit D.B. Atherogenesis: a postprandial phenomenon. Circulation. 60:1979;473-485.
4. Zilversmit D.B. Atherogenic nature of triglycerides, postprandial lipidemia, and triglyceride-rich remnant lipoproteins. Clin Chem. 41:1995;153-158.
5. Ellsworth J.L., Kraemer F.B., Cooper A.D. Transport of β-very low density lipoproteins and chylomicron remnants by macrophages is mediated by the low density lipoprotein receptor pathway. J Biol Chem. 262:1987;2316-2325.
6. Koo C., Wernette-Hammond M.E., Garcia Z., Malloy M.J., Uauy R., East C., Bilheimer D.W., Mahley R.W., Inneraity T.L. Uptake of cholesterol-rich remnant lipoproteins by human monocyte-derived macrophages is mediated by low density receptors. J Clin Invest. 81:1988;1332-1340.
7. Patsh J.R., Miesenböck G., Hopferwieser T., Mühlberger V., Knapp E., Dunn J.K., Gotto A.M. Jr., Patsh W. Relation of triglyceride metabolism and coronary disease. Arterioscler Thromb. 12:1992;1336-1345.
8. Groot P.H.E., van Stiphout W.A.H.J., Krauss X.H., Jansen H., van Tol A., van Ramshorst E., Chin-On S., Hofman A., Cresswell S.R., Havekes L. Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease. Arterioscler Thromb. 11:1991;653-662.
9. Karpe F., Steiner G., Olivecrona T., Carlson L.A., Hamsten A. Metabolism of triglyceride-rich lipoproteins during alimentary lipemia. J Clin Invest. 91:1993;748-758.
10. Weintraub M.S., Grosskopf I., Rassin T., Miller H., Charach G., Rotmensch H.H., Liron M., Rubinstein A., Iaina A. Clearance of chylomicron remnants in normolipidaemic patients with coronary artery disease: case control study over three years. Br Med J. 312:1996;935-939.
11. Phillips N.R., Waters D., Havel R.J. Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events. Circulation. 88:1993;2762-2770.
12. Nestel P., Billington T., Tada N., Nugent P., Fidge N. Heterogeneity of very-low-density lipoprotein metabolism in hyperlipidemic subjects. Metabolism. 32:1983;810-817.
13. Campos E., Nakajima K., Tanaka A., Havel R.J. Properties of an apolipoprotein E-enriched fraction of triglyceride-rich lipoprotein isolated from human blood plasma with a monoclonal antibody to apolipoprotein B-100. J Lipid Res. 33:1992;369-380.
14. Bergeron N., Havel R.J. Influence of diets rich in saturated and omega-6 polyunsaturated fatty acids on the postprandial responses of apolipoproteins B-48, B-100, E, and lipids in triglyceride-rich lipoproteins. Arterioscler Thromb Vasc Biol. 15:1995;2111-2121.
15. Nakajima K., Saito T., Tamura A., Suzuki M., Nakano T., Adachi M., Tanaka A., Tada N., Nakamura H., Campos E., Havel R.J. Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-1 immunoaffinity mixed gels. Clin Chim Acta. 223:1993;53-71.
16. Yasue H., Matsuyama K., Matsuyama K., Okumura K., Morigami Y., Ogawa H. Responses of angiographically normal human coronary arteries to intracoronary injection of acetylcholine by age and segment: possible role of early coronary atherosclerosis. Circulation. 81:1990;482-490.
17. Bossaller C., Habib G.B., Yamamoto H., Williams C., Wells S., Henry P.D. Impaired muscarinic endothelium-dependent relaxation and cyclic guanosine 5′-monophosphate formation in atherosclerotic human coronary artery and rabbit aorta. J Clin Invest. 79:1987;170-174.
18. Vita J.A., Treasure C.B., Nabel E.G., McLenachan J.M., Fish R.D., Yeung A.C., Vekshtein V.I., Selwyn A.P., Ganz P. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation. 81:1990;491-497.
19. Kugiyama K., Kerns S.A., Morrisett J.D., Roberts R., Henry P.D. Impairment of endothelium arterial relaxation by lysolecitin in modified low-density lipoproteins. Nature. 344:1990;160-162.
20. Mangin E.L. Jr., Kugiyama K., Nguy J.H., Kerns S.A., Henry P.D. Effects of lysolipids and oxidatively modified low density lipoprotein on endothelium-dependent relaxation of rabbit aorta. Circ Res. 72:1993;161-166.
21. Ohgushi M., Kugiyama K., Fukunaga K., Murohara T., Sugiyama S., Miyamoto E. Protein kinase C inhibitors prevent impairment of endothelium-dependent relaxation by oxidatively modified low-density lipoprotein. Arterioscler Thromb. 13:1993;1525-1532.
22. Bligh E.G., Dyer W.J. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 37:1959;911-917.
23. Weisgraber K.H., Innerarity T.L., Mahley R.W. Role of the lysine residues of plasma lipoproteins in high affinity binding to cell surface receptors on human fibroblasts. J Biol Chem. 253:1978;9053-9062.
24. Lowry O.H., Rosebrough N.J., Farr A.L., Raudi R.J. Protein measurement with folin phenol reagent. J Biol Chem. 193:1951;265-275.
25. Bartlett G.R. Phosphorus assay in column chromatography. J Biol Chem. 234:1959;466-468.
26. Matsumura T., Kugiyama K., Sugiyama S., Ohgushi M., Yamanaka K., Suzuki M., Yasue H. Neutral endopeptidase 24.11 in neutrophils modulates protective effects of natriuretic peptides against neutrophils-induced endothelial cytotoxity. J Clin Invest. 97:1996;2192-2203.
27. Kugiyama K., Ohgushi M., Sugiyama S., Murohara T., Fukunaga K., Miyamoto E., Yasue H. Lysophosphatidylcholine inhibits surface receptor-mediated intracellular signals in endothelial cells by a pathway involving protein kinase C activation. Circ Res. 71:1992;1422-1428.
28. MacFarlane A.S. Efficient trace-labeling of proteins with iodine. Nature. 182:1958;53.
29. Bilheimer D.W., Eisenberg S., Levy R.I. The metabolism of very low density lipoproteins, I: preliminary in vitro observations. Biochem Biophys Acta. 260:1972;212.
30. 2-macroglobulin receptor in vivo. J Biol Chem. 268:1993;14168-14175.
31. Sugiyama S., Kugiyama K., Matsumura T., Suga S., Itoh H., Nakao K., Yasue H. Lipoproteins regulate C-type natriuretic peptide secretion from cultured vascular endothelial cells. Arterioscler Thromb Vasc Biol. 15:1995;1968-1974.
32. Hertz J., Hamann U., Rogne S., Myklebost O., Gausepohl H., Stanley K.K. Surface location and high affinity for calcium of a 500-kd liver membrane protein closely related to the LDL-receptor suggest a physiological role as lipoprotein receptor. EMBO J. 7:1988;4119-4127.
33. Ji Z.-S., Brecht W.J., Miranda R.D., Hussain M.M., Innerarity T.L., Mahley R.W. Role of heparan sulfate proteoglycans in the binding and uptake of apoprotein E-enriched remnant lipoproteins by cultured cells. J Biol Chem. 268:1993;10160-10167.
34. Luoma J., Hiltunen T., Särkioja T., Moestrup S.K., Gliemann J., Kodama T., Nikkari T., Ylä-Herttuala S. Expression of alpha2-macroglobulin receptor/low density lipoprotein receptor-related protein and scavenger receptor in human atherosclerotic lesions. J Clin Invest. 93:1994;2014-2021.
35. Suzuki J., Takahashi S., Oida K., Shimada A., Kohno M., Tamai T., Miyabo S., Yamamoto T., Nakai T. Lipid accumulation and foam cell formation in Chinese hamster ovary cells overexpressing very low density lipoprotein receptor. Biochem Biophys Res Commun. 206:1995;835-842.
36. Multhaupt H.A.B., Gåfvels M., Kariko K., Jin H., Arenas-Elliott C., Goldman B.I., Strauss J.F. III, Angelin B., Warhol M.J., McCrae K.R. Expression of very low density lipoprotein receptor in the vascular wall: analysis of human tissues by in situ hybridization and immunochemistry. Am J Pathol. 148:1996;1985-1997.
37. Cowan C.L., Palancino J.J., Najibi S., Cohen R.A. Potassium channel-mediated relaxation to acetylcholine in rabbit arteries. J pharmacol Exp Ther. 266:1993;1482-1489.
38. Saxena U., Klein M.G., Goldberg I.J. Metabolism of endothelial cell-bound lipoprotein lipase. J Biol Chem. 265:1990;12880-12886.
39. Argraves K.M., Battey F.D., MacCalman C.D., McCrae K.R., Gåfvels M., Kozarsky K.F., Chappell D.A., Strauss J.F. III, Strickland D.K. The very low density lipoprotein receptor mediates the cellular catabolism of lipoprotein lipase and urokinase-plasminogen activator inhibitor type I complexes. J Biol Chem. 270:1995;26550-26557.
40. Ji Z.-S., Mahley R.W. Lactoferrin binding to heparin sulfate proteoglycans and the LDL receptor-related protein: further evidence supporting the importance of direct binding of remnant lipoproteins to HSPG. Arterioscler Thromb. 14:1994;2025-2032.
41. 2-macroglobulin receptor is induced by the C-terminal domain of lipoprotein lipase. J Biol Chem. 269:1994;18001-18006.
42. Heery J.M., Kozak M., Stafforini D.M., Jones D.A., Zimmerman G.A., Mclntyre T.M., Prescott S.M. Oxidatively modified LDL contains phospholipids with platelet-activating factor-like activity and stimulates the growth of smooth muscle cells. J Clin Invest. 96:1995;2322-2330.
43. Flavahan N.A. Atherosclerosis or lipoprotein-induced endothelial dysfunction: Potential mechanisms underlying reduction in EDRF/nitric oxide activity. Circulation. 85:1992;1927-1938.
44. i2 subunit expression by oxidized low-density lipoprotein. J Clin Invest. 95:1995;1457-1463.
45. Duell P.B., Bierman E.L. Potential role of insulin in the clearance of remnant lipoproteins in dysbetalipoproteinemia. J Intern Med. 229:1991;97-101.
46. Kane J.P., Chen G.C., Hamilton R.L., Hardman D.A., Malloy M.J., Havel R.J. Remnants of lipoproteins of intestinal and hepatic origin in familial dysbeta lipoproteinemia. Arteriosclerosis. 3:1983;47-56.